Mary Collins (immunologist)

Last updated
Mary Collins
Born
Mary Katharine Levinge Collins
NationalityBritish
Alma mater
Known forDevelopment of lentivirus viral vectors
Spouse
​
(m. 1995)​
[1]
ChildrenTwo daughters, [1] born c. 1994 and 1998
Awards FMedSci
Scientific career
Fields Immunology
Institutions
Thesis The mechanism of action of mitogens for cultured murine fibroblasts : regulation of mitogenic receptors and response  (1983)
Academic advisorsEnrique Rozengurt, Richard C. Mulligan
Website iris.ucl.ac.uk/iris/browse/profile?upi=MKLCO33

Mary Katharine Levinge Collins, Lady Hunt is a British Professor of virology and the director of the Queen Mary University of London Blizard Institute. She served as Provost at the Okinawa Institute of Science and Technology in Japan. Formerly, Collins taught in the Division of Infection and Immunity at University College London, and was the head of the Division of Advanced Therapies at the National Institute for Biological Standards and Control, and the Director of the Medical Research Council Centre for Medical Molecular Virology. Her research group studies the use of viruses as vectors for introducing new genes into cells, which can be useful for experimental cell biology, for clinical applications such as gene therapy, and as cancer vaccines. [2] [3] [4] [5] [6]

Contents

Education

Collins was born in Reading, England and grew up in Cheltenham Spa, attending Cheltenham Ladies' College as a day girl. She won an entrance scholarship to Clare College, Cambridge, where she studied Natural Sciences (Biochemistry).[ citation needed ] She did her postgraduate research work supervised by Enrique Rozengurt at the Imperial Cancer Research Fund for which she was awarded a PhD by the University of London in 1983. [7]

Career and research

After her PhD, she moved to a postdoctoral fellowship with Avrion Mitchison at University College London studying the locations of T cell receptor gene clusters, and next worked with Richard C. Mulligan at the Whitehead Institute at the Massachusetts Institute of Technology, where she developed retroviral vectors expressing cytokines and cytokine receptors. [3]

Collins started her research group in 1987 at the Institute of Cancer Research in London and moved in 1997 to University College London, where she has since held a variety of leadership positions. She served as the head of UCL Immunology & Molecular Pathology from 2000 to 2007, became Director of the Medical Research Council Centre for Medical Molecular Virology in 2005, became Director of the UCL Division of Infection & Immunity in 2003, and served as the Dean of the Faculty of Life Sciences between 2009 and 2014. She stepped down as dean to become the head of the Division of Advanced Therapies at the National Institute for Biological Standards and Control. [3] [8]

Collins was among the prominent UCL women scientists featured in a series of interviews published by the MRC in celebration of International Women's Day in 2011 [9] and was one of two UCL women to participate in a women in science event in collaboration with Central Saint Martins College of Art and Design in 2012. In December 2015, it was announced that Professor Collins would become Dean of Research at the Okinawa Institute of Technology. Forbes Magazine speculated that she would supervise of $110m in Japanese government funding at the Institute. [10] [11] She was appointed Provost in 2018 and lead the University's response to the COVID-19 pandemic.

In October 2022, she returned to London to take up the post of Director of the Blizard Institute, Queen Mary University of London. [12]

Collins' research group studies the use of viruses, particularly lentiviruses (the group to which the human immunodeficiency virus belongs), as vectors for delivering novel genes to cells and as platforms for the development of vaccines. [2] Because lentiviruses like HIV specifically infect immune cells called T-cells, a genetically engineered inactivated version of the virus can be used to deliver immunogenic proteins to T-cells to induce an immune response. This system has been studied successfully in laboratory mice. [13] [14]

Awards and honours

Collins was elected a Fellow of the Academy of Medical Sciences (FMedSci)in 1999. [3]

She won the Suffrage Science award in 2011. [15]

Personal

Collins married Tim Hunt in 1995, [1] who was awarded the Nobel Prize in Physiology or Medicine in 2001, and knighted in 2006. They have two children. [16]

Related Research Articles

Lentivirus is a genus of retroviruses that cause chronic and deadly diseases characterized by long incubation periods, in humans and other mammalian species. The genus includes the human immunodeficiency virus (HIV), which causes AIDS. Lentiviruses are distributed worldwide, and are known to be hosted in apes, cows, goats, horses, cats, and sheep as well as several other mammals.

Viral vectors are tools commonly used by molecular biologists to deliver genetic material into cells. This process can be performed inside a living organism or in cell culture. Viruses have evolved specialized molecular mechanisms to efficiently transport their genomes inside the cells they infect. Delivery of genes or other genetic material by a vector is termed transduction and the infected cells are described as transduced. Molecular biologists first harnessed this machinery in the 1970s. Paul Berg used a modified SV40 virus containing DNA from the bacteriophage λ to infect monkey kidney cells maintained in culture.

Gillian Patricia Bates FMedSci FRS is a British biologist. She is distinguished for her research into the molecular basis of Huntington's disease and in 1998 was awarded the GlaxoSmithKline Prize as a co-discoverer of the cause of this disease. As of 2016, she is Professor of Neurogenetics at UCL Institute of Neurology and the co-director of UCL Huntington's Disease Centre.

<span class="mw-page-title-main">Janice E. Clements</span> American biologist, academic and medical researcher

Janice Ellen Clements is vice dean for faculty at the Johns Hopkins School of Medicine and the Mary Wallace Stanton Professor of Faculty Affairs. She is a professor in the departments of Molecular and Comparative Pathobiology, Neurology, and Pathology, and has a joint appointment in molecular biology and genetics. Her molecular biology and virology research examines lentiviruses and how they cause neurological diseases.

M. Christine "Chris" Zink is the director of the Department of Molecular and Comparative Pathobiology at the Johns Hopkins School of Medicine. She also holds professorships in the Department of Pathology at Johns Hopkins and in the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. Zink researches the response of the immune system to retroviruses such as HIV and is currently investigating an animal model of antiretroviral therapy and the potential of a common antibiotic to prevent HIV-associated neurocognitive disorders.

<span class="mw-page-title-main">Biomedical sciences</span> Application of science to healthcare

Biomedical sciences are a set of sciences applying portions of natural science or formal science, or both, to develop knowledge, interventions, or technology that are of use in healthcare or public health. Such disciplines as medical microbiology, clinical virology, clinical epidemiology, genetic epidemiology, and biomedical engineering are medical sciences. In explaining physiological mechanisms operating in pathological processes, however, pathophysiology can be regarded as basic science.

Herpes simplex research includes all medical research that attempts to prevent, treat, or cure herpes, as well as fundamental research about the nature of herpes. Examples of particular herpes research include drug development, vaccines and genome editing. HSV-1 and HSV-2 are commonly thought of as oral and genital herpes respectively, but other members in the herpes family include chickenpox (varicella/zoster), cytomegalovirus, and Epstein-Barr virus. There are many more virus members that infect animals other than humans, some of which cause disease in companion animals or have economic impacts in the agriculture industry.

<span class="mw-page-title-main">HIV/AIDS research</span> Field of immunology research

HIV/AIDS research includes all medical research that attempts to prevent, treat, or cure HIV/AIDS, as well as fundamental research about the nature of HIV as an infectious agent and AIDS as the disease caused by HIV.

<span class="mw-page-title-main">Lentiviral vector in gene therapy</span>

Lentiviral vectors in gene therapy is a method by which genes can be inserted, modified, or deleted in organisms using lentiviruses.

Jane A. McKeating is a professor of molecular biology at Oxford University, and honorary professor at the University of Birmingham, England, where she worked as a professor of molecular virology until 2017. She is listed as a notable scientist in Thomson Reuters' Highly Cited Researchers 2014, ranking her among the top 1% most cited scientists.

Anna-Lise WilliamsonMASSAf is a Professor of Virology at the University of Cape Town. Williamson obtained her PhD from the University of the Witwatersrand in 1985. Her area of expertise is human papillomavirus, but is also known on an international level for her work in developing vaccines for HIV. These vaccines have been introduce in phase 1 of clinical trial. Williamson has published more than 120 papers.

<span class="mw-page-title-main">Maurice Green (virologist)</span> American virologist

Maurice Green was an American virologist. He is regarded as a pioneer in the study of animal viruses, in particular their role in cancer. Green founded the Institute of Molecular Virology at St. Louis University School of Medicine in the late 1950s, and later served as its chairman.

Gary J. Nabel is an American virologist and immunologist who is President and chief executive officer of ModeX Therapeutics in Natick, Massachusetts.

<span class="mw-page-title-main">Sean Whelan (scientist)</span> British-American virologist

Sean Whelan is a British-American virologist. He is known for identifying the cellular protein used as a receptor by Ebola virus, for defining the entry pathway that rabies virus uses to enter neurons, and for identifying the ribosome as a possible target for antiviral drugs. In July 2019, he was announced as the new Chair of the Department of Molecular Microbiology at Washington University School of Medicine in St Louis, Missouri. In February 2020, Whelan was recognized as the LGBTQ+ Scientist of the Year 2020 by the National Organization of Gay and Lesbian Scientists and Technical Professionals.

Judith Breuer is a British virologist who is professor of virology and director of the Pathogen Genomics Unit at University College London. She was elected a Fellow of the Academy of Medical Sciences in 2019. Breuer is part of the United Kingdom genome sequencing team that looks to map the spread of the coronavirus disease 2019.

<span class="mw-page-title-main">Vanessa M. Hirsch</span> Canadian-American veterinary pathologist and scientist

Vanessa M. Hirsch is a Canadian-American veterinary pathologist and scientist. She is a senior investigator and chief of the nonhuman primate virology section at the National Institute of Allergy and Infectious Diseases. Hirsch researches AIDS pathogenesis, the evolution and origins of primate lentiviruses, and HIV vaccine development.

Jason S. McLellan is a structural biologist, professor in the Department of Molecular Biosciences and Robert A. Welch Chair in Chemistry at The University of Texas at Austin who specializes in understanding the structure and function of viral proteins, including those of coronaviruses. His research focuses on applying structural information to the rational design of vaccines and other therapies for viruses, including SARS-CoV-2, the novel coronavirus that causes COVID-19, and respiratory syncytial virus (RSV). McLellan and his team collaborated with researchers at the National Institute of Allergy and Infectious Diseases’ Vaccine Research Center to design a stabilized version of the SARS-CoV-2 spike protein, which biotechnology company Moderna used as the basis for the vaccine mRNA-1273, the first COVID-19 vaccine candidate to enter phase I clinical trials in the U.S. At least three other vaccines use this modified spike protein: those from Pfizer and BioNTech; Johnson & Johnson and Janssen Pharmaceuticals; and Novavax.

Mavis Agbandje-McKenna was a Nigerian-born British medical biophysicist, structural virologist, and a professor of structural biology, as well as the director of the Center for Structural Biology at the University of Florida in Gainesville, Florida. Agbandje-McKenna studied parvovirus structures using X-ray crystallography and cryogenic electron microscopy and did much of the initial work to elucidate the basic structure and function of adeno-associated viruses (AAVs). Her viral characterization and elucidation of antibody binding sites on AAV capsids has led to the development of viral capsid development and gene therapy approaches that evade immune detection and can be used to treat human diseases such as muscular dystrophies. Agbandje-McKenna was recognized with the 2020 American Society of Gene and Cell Therapy Outstanding Achievement Award for her contributions to the field. She died in 2021 from amyotrophic lateral sclerosis.

Theodora Hatziioannou is a Greek-American virologist. She known for her work discovering restriction factors that counteract HIV-AIDS and other primate lentiviruses, thus restricting them to specific species, and making it hard to study HIV-1 in animals. Her findings allowed her to develop the first HIV-1-based virus which is capable of recapitulating AIDS-like symptoms in a non-hominid. She is a Research Associate Professor in the Laboratory of Retrovirology at The Rockefeller University in New York. She is a co-author of a textbook on virology, Principles of Virology.

William Paul Duprex is a British scientist and advocate for vaccines and global health. He serves as Director of the University of Pittsburgh's Center for Vaccine Research and Regional Biocontainment Laboratory. Duprex holds the Jonas Salk Chair in Vaccine Research. He is also a professor of microbiology and molecular genetics at the University of Pittsburgh School of Medicine and serves as Editor-in-Chief of the Journal of General Virology, which is published by the Microbiology Society, and a senior editor of mSphere, published by the American Society for Microbiology. Duprex is an expert in measles and mumps viruses and studies viral spillover from animals to humans, including the SARS-CoV-2 virus that caused the COVID-19 pandemic. Duprex is a Fellow of the American Academy of Microbiology.

References

  1. 1 2 3 "HUNT, Sir Tim" . Who's Who . Vol. 1992 (online Oxford University Press  ed.). A & C Black.(Subscription or UK public library membership required.)
  2. 1 2 "Prof Mary Collins". University College London. Archived from the original on 15 June 2015. Retrieved 11 June 2015.
  3. 1 2 3 4 "Professor Mary Collins". National Institute for Biological Standards and Control. Retrieved 11 June 2015.
  4. ↑ "People, Medical Molecular Virology". University College London. Archived from the original on 13 June 2015. Retrieved 11 June 2015.
  5. ↑ "Mary Collins website @UCL". ucl.ac.uk. Archived from the original on 2015-06-15.
  6. ↑ "Mary Collins appointed as Director of Queen Mary's Blizard Institute". EurekAlert!.
  7. ↑ Collins, Mary Katharine Levinge (1983). The mechanism of action of mitogens for cultured murine fibroblasts : regulation of mitogenic receptors and response (PhD thesis). University of London. OCLC   941030795.
  8. ↑ "New leadership team for the UCL School of Life & Medical Sciences". University College London. 30 June 2009. Retrieved 11 June 2015.
  9. ↑ "Leading UCL researchers celebrate women's contribution to science". University College London. 10 March 2011. Retrieved 11 June 2015.
  10. ↑ "Women in Science: Nurturing Nobels". University College London. 12 March 2012. Retrieved 11 June 2015.
  11. ↑ Robin McKie (2015-12-19). "Tim Hunt and Mary Collins: 'We're not being chased out of the country. Our new life's an adventure'". theguardian.com. The Guardian . Retrieved 2015-12-28.
  12. ↑ Mary Collins appointed as Director of Queen Mary's Blizard Institute, qmul.ac.uk. Accessed 12 December 2022.
  13. ↑ Collins, MK; Cerundolo, V (December 2004). "Gene therapy meets vaccine development". Trends in Biotechnology. 22 (12): 623–6. doi:10.1016/j.tibtech.2004.10.006. PMID   15542151.
  14. ↑ McKie, Robin (23 April 2011). "Mary Collins: HIV can help fight disease". The Guardian. Retrieved 11 June 2015.
  15. ↑ "UCL scientists to be recognised at Suffrage Science event". UCL News. 28 February 2013.
  16. ↑ "Biozentrum Lectures 2010". Universität Basel. Retrieved 11 June 2015.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.